Universal Vision Biotechnology Co., Ltd. (TPEX:3218)

TPEX:3218 Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	568.01	506.85	1,063	703.02	534.19	616
Short-Term Investments	82.27	115.22	578.36	576.62	505.81	461.75
Trading Asset Securities	1,133	1,295	-	-	-	-
Cash & Short-Term Investments	1,783	1,917	1,641	1,280	1,040	1,078
Cash Growth	21.82%	16.85%	28.23%	23.04%	-3.50%	51.56%
Accounts Receivable	526.07	565.57	584.25	581.82	534.93	377.13
Other Receivables	9.06	11.9	2.17	3.37	11.31	33.8
Receivables	535.13	577.47	586.42	585.18	546.25	410.92
Inventory	324.2	289.73	294.52	227.62	115.65	62.62
Other Current Assets	66.28	57.19	58.03	66.54	77.21	90.78
Total Current Assets	2,709	2,842	2,580	2,159	1,779	1,642
Property, Plant & Equipment	2,725	2,673	2,323	2,206	1,724	1,413
Long-Term Investments	100.06	111.07	-	-	-	-
Other Intangible Assets	21.45	22.79	22.98	25.91	26.57	26.52
Long-Term Deferred Tax Assets	77.44	72.26	67.25	55.91	48.31	34.47
Other Long-Term Assets	53.77	41.34	137.06	59.25	171.76	53.11
Total Assets	5,686	5,763	5,131	4,506	3,750	3,169
Accounts Payable	280.77	268.07	312.31	254.55	210.5	122.93
Accrued Expenses	-	226.34	226.54	210.26	170.08	128.1
Short-Term Debt	301.32	92.01	8.67	-	-	176.9
Current Portion of Long-Term Debt	-	-	1.3	9.17	9.03	-
Current Portion of Leases	182.65	178.4	155.27	141.45	130.72	108
Current Income Taxes Payable	165.35	154.45	162.57	134.37	85.7	77.44
Current Unearned Revenue	-	25.12	24.19	23.32	16.24	14.22
Other Current Liabilities	362.07	146.34	132.25	137.25	109.39	125.83
Total Current Liabilities	1,292	1,091	1,023	910.38	731.66	753.41
Long-Term Debt	-	-	-	1.32	10.33	-
Long-Term Leases	790.08	783.83	613.02	631.7	617.45	329.24
Long-Term Deferred Tax Liabilities	56.98	60.93	58.39	44.26	24.94	-
Other Long-Term Liabilities	54.51	71.49	93.12	88.8	36.78	47.04
Total Liabilities	2,194	2,007	1,788	1,676	1,421	1,130
Common Stock	847.25	847.25	847.25	799.29	761.23	761.23
Additional Paid-In Capital	381.92	381.92	381.92	381.92	381.92	381.92
Retained Earnings	2,158	2,388	1,960	1,488	1,056	779.86
Comprehensive Income & Other	-29.39	4.51	-11.38	-5.04	-10.37	-9.12
Total Common Equity	3,358	3,622	3,178	2,664	2,188	1,914
Minority Interest	134.74	133.72	165.33	165.02	140.13	125.55
Shareholders' Equity	3,493	3,756	3,343	2,829	2,328	2,039
Total Liabilities & Equity	5,686	5,763	5,131	4,506	3,750	3,169
Total Debt	1,274	1,054	778.26	783.65	767.53	614.14
Net Cash (Debt)	509.3	863.2	862.65	495.99	272.47	463.61
Net Cash Growth	-14.82%	0.07%	73.92%	82.03%	-41.23%	261.16%
Net Cash Per Share	5.99	10.16	10.16	5.85	3.21	5.46
Filing Date Shares Outstanding	85.02	84.73	84.73	84.72	84.72	84.72
Total Common Shares Outstanding	85.02	84.73	84.73	84.72	84.72	84.72
Working Capital	1,417	1,751	1,557	1,249	1,047	888.66
Book Value Per Share	39.50	42.75	37.51	31.45	25.83	22.59
Tangible Book Value	3,336	3,599	3,155	2,638	2,162	1,887
Tangible Book Value Per Share	39.24	42.48	37.23	31.14	25.52	22.28
Land	-	179.87	179.87	179.87	179.87	179.87
Buildings	-	67.11	67.11	66.76	66.76	66.65
Machinery	-	2,442	2,165	1,884	1,480	1,346
Construction In Progress	-	96.01	32.82	91.84	-	-
Leasehold Improvements	-	643.69	615.67	473.07	340.85	306.52

Source: S&P Global Market Intelligence. Standard template. Financial Sources.